From stock-market transactions and confidential information to preferential deals, private investments and market-moving decisions — how politicians, central bankers and public officials can gain financial advantages unavailable to ordinary investors. In June 2017, US Congressman Christopher Collins received confidential information that a biotechnology company in which he was a major shareholder had suffered a serious […]
-
Subscribe
Subscribed
Have a WordPress.com account? Log in now.
